IKS Health acquires TruBridge in $557 million deal
Inventurus Knowledge Solutions Inc. (IKS Health) agreed to acquire TruBridge Inc. for approximately $557 million in a cash buyout, the companies announced Tuesday. The deal, which includes $427 million in equity value and $130 million in assumed debt, will result in TruBridge being delisted, with IKS Health expecting the acquisition to be accretive to earnings per share starting in fiscal 2027, according to company officials.
Under the terms of the agreement announced April 23, 2026, TruBridge shareholders will receive $26.25 in cash per share of common stock upon closing, according to a joint press release from Inventurus Knowledge Solutions Inc. (IKS Health) and TruBridge Inc. The transaction carries an enterprise value of approximately $557 million, comprised of $427 million in equity value and the assumption of about $130 million in TruBridge debt, company officials said. The acquisition will result in TruBridge being delisted from the NASDAQ stock exchange, where it trades under the ticker TBRG.
The acquisition is expected to be accretive to IKS Health’s earnings per share starting in fiscal year 2027, after factoring in TruBridge’s adjusted EBITDA of approximately $69 million and incremental interest costs associated with the new debt, according to IKS management and research reports.
IKS Health plans to finance the deal primarily through new indebtedness, including a five-year term loan facility at SOFR plus 275 basis points, underwritten by a consortium led by Citibank, JPMorgan Chase, and Deutsche Bank. The consortium has committed up to $670 million in financing to support the acquisition and related capital needs, according to sources familiar with the transaction. Analysts and company commentary estimate that roughly $600 million of new debt will be raised to fund the $557 million enterprise value deal.
The combined entity is projected to generate about $698 million in annual revenue and $186 million in adjusted EBITDA at closing, company documents indicate. TruBridge currently contributes roughly $347 million in annual revenue, primarily from providing electronic health records (EHR) and revenue cycle management (RCM) solutions to more than 1,500 healthcare organizations, mainly rural and community hospitals across the United States.
IKS Health, headquartered in Mumbai, India, with key U.S. operations based in Dallas, Texas, describes itself as a global leader in care enablement solutions. TruBridge is recognized as a prominent provider of healthcare technology services to rural and community hospitals in the U.S., according to the companies’ joint release and market analysis. The strategic rationale for the acquisition centers on combining IKS’s AI-driven “system of action” with TruBridge’s “system of record” platform, integrating EHR and RCM capabilities to create a unified operating platform for healthcare providers. Analysts note the transaction targets the $164 billion rural healthcare market in the U.S., where TruBridge has established a strong presence.
The integration is expected to unlock recurring revenue streams and significant cross-sell opportunities estimated at more than $575 million, leveraging the combined client base, according to research reports from ICICI Direct and other financial analysts. Post-transaction, the merged entity will serve over 2,000 healthcare organizations and approximately 150,000 clinicians, deal analysis shows. The deal is the largest acquisition to date for IKS Health and represents a major expansion of its footprint in the U.S. healthcare technology market, sources said.
The boards of directors of IKS Health, its U.S. subsidiary Inventurus Knowledge Solutions Inc., and TruBridge have approved the transaction, the companies confirmed. The deal is expected to close in the third calendar quarter of 2026, subject to customary closing conditions, including requisite shareholder approvals and compliance with the Hart-Scott-Rodino antitrust notification and waiting period in the United States. Financial disclosures note that while the enterprise value and per-share cash consideration are fixed, the final gross debt figure and closing date could vary slightly depending on market conditions at closing.
Following the acquisition, IKS projects gross debt of roughly ₹5,400 crore (approximately $600 million), with management targeting a reduction to about ₹300 crore net debt by fiscal year 2030 while growing EBITDA to ₹3,000 crore. The new debt package is structured to support these financial goals, according to company officials and banking sources.
TruBridge’s adjusted EBITDA multiple implied by the transaction is approximately 8 to 8.1 times, based on the $557 million enterprise value and $69 million EBITDA figure. Analysts highlight that after accounting for estimated annual interest expenses of around $36 million and intangible asset amortization, the transaction remains accretive to earnings from the date of closing.
The companies issued a joint press release titled “IKS Health Announces Agreement to Acquire TruBridge to Strengthen Access to Rural and Community-Based Healthcare” on April 23, 2026, with datelines from Mumbai, Dallas, and Mobile, Alabama. Financial media outlets including Moneycontrol and CNBC TV18 have reported on the deal, with CNBC featuring interviews with IKS leadership outlining the acquisition’s anticipated impact on margins and leverage.
IKS Health is a subsidiary of Inventurus Knowledge Solutions Limited, listed on the National Stock Exchange of India under the ticker IKS. TruBridge is a U.S.-based company focused on healthcare IT solutions for smaller hospitals and community health systems. The acquisition aligns with IKS’s strategic objective to deepen its role in rural healthcare technology and expand its integrated care enablement offerings across the United States.
